Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
479.00    2.00 (0.42%)
Bid:
477.00
Ask:
480.00
Spread: 3.00 (0.629%)
Market Cap: £790.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director Dealing

28 Jun 2018 18:20

RNS Number : 9785S
Oakley Capital Investments Limited
28 June 2018
Β 

28 June 2018

Β 

Β 

Oakley Capital Investments Limited

Β 

Director Dealing

Β 

Oakley Capital Investments Limited1 (AIM: OCI, the "Company"), was notified today of the following transactions by a Director of the Company:

Β 

Peter Dubens, a Director of the Company, has purchased 1,500,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at an aggregate price of 183.5 pence per Ordinary Share. As a result, Mr. Dubens is now interested in 9,085,052 Ordinary Shares of the Company, representing 4.436 per cent. of the issued share capital.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Peter Dubens

2

Reason for the notification

Β 

a)

Position/status

Β 

Non-Executive Director

b)

Initial notification/ Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Β 

Oakley Capital Investments Limited

b)

LEI

Β 

213800KW6MZUK12CQ815

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary Shares of 1p each

Β 

Β 

Β 

Β 

BMG670131058

b)

Nature of the transaction

Β 

Β 

Acquisition

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Β 183.5p

Β 

Β 

1,500,000

Β 

Β 

Β 

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

1,500,000

Β 

Β 

183.5p

e)

Date of the transaction

Β 

28 June 2018

f)

Place of the transaction

Β 

London Stock Exchange, AIM

Β 

Β 

Β 

- ends -

Β 

Β 

For further information please contact:

Β 

Oakley Capital Investments Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

Β 

Greenbrook Communications Ltd

+44 20 7952 2000

Alex Jones / Matthew Goodman / Gina Bell

Β 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Jill Li

Β 

Β 

1About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

Β 

LEI Number: 213800KW6MZUK12CQ815

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHDVLFLVQFFBBD
Date   Source Headline
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment
14th Nov 20183:58 pmRNSDirector Dealing
8th Nov 20187:00 amRNSInvestment Activity Update
24th Oct 20181:30 pmRNSDirector Dealing
12th Oct 20183:07 pmRNSDirector Dealing
25th Sep 20187:00 amRNSAppointment of Non-Executive Director
11th Sep 20187:00 amRNSBoard Changes
6th Sep 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSOakley Capital to invest in cPanel
27th Jul 20184:40 pmRNSHolding(s) in Company
26th Jul 20187:00 amRNSTrading Update
6th Jul 20187:00 amRNSOakley agrees sale of Damovo to Eli Global
4th Jul 20183:49 pmRNSResult of AGM
28th Jun 20186:21 pmRNSDirector Dealing
28th Jun 20186:20 pmRNSDirector Dealing
26th Jun 201811:29 amRNSDirector Dealing
21st Jun 20187:00 amRNSNotice of Annual General Meeting
11th Jun 20187:00 amRNSPlesk acquisition of SolusVM
24th May 20187:00 amRNSOakley agrees sale of Facile to EQT
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20183:35 pmRNSDirector/PDMR Shareholding
26th Apr 20183:34 pmRNSDirector/PDMR Shareholding
13th Apr 20182:00 pmRNSDirector/PDMR Shareholding
20th Mar 201812:54 pmRNSDividend Announcement
15th Mar 20187:00 amRNSFinal Results
6th Mar 201811:57 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSSale of PARSHIP ELITE Group and Verivox
31st Jan 20187:00 amRNSTrading Update
18th Jan 20185:26 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSAcquisition of Career Partner Group
19th Sep 20177:00 amRNSDirector/PDMR Shareholding
15th Sep 20178:57 amRNSDirector/PDMR Shareholding
12th Sep 20177:00 amRNSHalf-year Report
3rd Aug 20177:00 amRNSTrading Update
31st Jul 20177:00 amRNSChange of Stock Ticker
28th Jul 20177:00 amRNSInspired welcomes TA Associates as an investor
10th Jul 20173:10 pmRNSCompletion of Schülerhilfe Acquisition
20th Jun 201712:42 pmRNSHolding(s) in Company
16th Jun 201711:03 amRNSResult of AGM
26th May 20177:00 amRNSCompletion of TechInsights Acquisition
16th May 20175:30 pmRNSDirector/PDMR Shareholding
16th May 20177:00 amRNSAcquisition of Schuelerhilfe
15th May 20177:00 amRNSAcquisition of TechInsights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.